Melanoma In Situ
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms (NCT05402046) | MelanomaPRO, Russia | 2022-04-23 |
| Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice (NCT05402059) | MelanomaPRO, Russia | 2022-03-02 |
| Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm (NCT04695015) | Peking University | 2020-12-31 |
| Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2 (NCT03233828) | Carman Giacomantonio | 2019-10-30 |
| Mohs and Immunofluorescence for Malignant Melanoma In Situ (NCT02306512) | University of Miami | 2015-06-01 |
| BioMEL- Diagnostic and Prognostic Factors in Melanoma. (NCT05446155) | Region Skane | 2013-11-04 |
Track Melanoma In Situ automatically
Every clearance here is in the API, with alerts when new ones post.